NHS England support and funding for Cancer Alliances

Cancer Alliances and NHS England work closely together to deliver the five year cancer strategy. There are 19 Cancer Alliances across the country that bring together local clinical and managerial staff  from providers and other healthcare organisations, to implement the strategy and transform cancer care and support for patients.

Cancer Alliances look at the care and support patients should expect to receive from diagnosis to follow-up support across whole populations of patients, so they can address variations and implement best practice. NHS England provides both direct and indirect funding, support and guidance to Cancer Alliances in their work.

Programme Funding and support for Cancer Alliances

NHS England has confirmed funding of over £600 million to support delivery of the strategy which has been set out clearly for the four years to 2020/21.

Support that all Cancer Alliances will receive in 2018/19 to transform care for their cancer patients includes:

  • Core funding to establish and maintain a team to support the new way of working led by the Alliance
  • Transformation Funding to deliver improvements in early diagnosis and quality of life for people living with and beyond cancer
  • Dedicated support from our new analysis, evidence and data service
  • Support and assurance from NHS England regional offices
  • A tailored development programme
  • A series of national Cancer Alliance events to share best practice and information across Cancer Alliances.

Additional funding is also available to qualifying Cancer Alliances through:

  • Support to deliver the 20/18 Planning Guidance priorities for cancer
  • Pilots supporting the roll-out of national commitments such as the Faster Diagnosis Standard and the Quality of Life Metric
  • Ongoing support for rolling out the largest radiotherapy modernisation programme in 15 years
  • Extending the low dose CT scanning service to help spot lung cancer earlier.

Transformation Funding

We are on track to invest at least £200 million in Transformation Funding for the two financial years from 2017/18 to 2018/19 – supporting Alliances to deliver earlier and faster diagnosis and improved quality of life for people with cancer.

NHS England works with Cancer Alliances to make sure funding goes to areas that have robust plans for effective use of these funds, and who, through their day to day operations, have established a solid foundation for transforming care. As a result, an element of the funding released to support each Alliance in 2018/19 is linked to their 62 day performance.

Transformation funding 2017/18

Over £72 million was released in 2017/18 to support Cancer Alliances to transform cancer services as part of our five year cancer strategy. A further £9 million went to Greater Manchester which is part of a devolution agreement.

A significant level of Transformation Funding was released to support work and projects around early diagnosis. This is work that will help to ensure that patients receive their cancer diagnosis more quickly and while their cancer is at an early stage.

Transformation Funding released to support Living With and Beyond Cancer projects is improving quality of life for patients by strengthening Stratified Follow Up pathways, ensuring a whole person, whole pathway, personalised approach to care, as well as implementing the Recovery Package.

The Programme has also provided additional funding, separate to Transformation Funding, to support the Faster Diagnosis pilot sites and Quality of Life Metric pilot sites.

Some specific examples of 2017/18 transformation projects are:

Transformation Funding 2018/19

For this year, all Cancer Alliances have agreed plans in place for using Transformation Funding to deliver earlier and faster diagnosis and support for people living with and beyond cancer, while prioritising the delivery of the 2018/19 Planning Guidance.

Transformation Funding is being agreed at two points during the financial year 2018/19. Funding for the first half of 2018/19 is set out in the table below.

Funding provided to Cancer Alliances in the first half of the financial year (Q1 and Q2) 2018/19*
Cancer Alliance Total – (£)
Northern 3,435,000
Lancashire & South Cumbria 1,887,000
Cheshire & Merseyside 2,450,000
West Yorkshire & Harrogate 2,874,000
Humber, Coast & Vale 1,353,000
South Yorkshire 1,861,000
West Midlands 3,989,000
East Midlands 4,350,000
East of England 7,510,000
South East London 1,241,000
RM Partners 5,505,000
UCLH Cancer Collaborative 3,873,000
Thames Valley 3,046,000
Kent & Medway 1,225,000
Surrey & Sussex 1,762,000
Somerset, Wiltshire, Avon & Gloucestershire 2,445,000
Peninsula 1,727,000
Wessex 2,256,000
Sub-total 52,789,000
Capital (subject to approval) 29,680,000
Greater Manchester (devolution agreement) 14,500,000
Grand total 96,969,000

*Notes to table:

  1. Figures include programme funding for Q1 and Q2 2018/19, plus core team funding for the whole financial year.
  2. Capital funding and funding for Greater Manchester are full year figures for 2018/19.